Anterogen Co Ltd (065660)

Currency in KRW
24,000
+850(+3.67%)
Closed·
065660 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
065660 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22,90024,000
52 wk Range
13,70029,650
Key Statistics
Bid/Ask
23,950.00 / 24,000.00
Prev. Close
23,150
Open
23,150
Day's Range
22,900-24,000
52 wk Range
13,700-29,650
Volume
10.98K
Average Volume (3m)
38.1K
1-Year Change
76.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
065660 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Anterogen Co Ltd Company Profile

Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of cell therapy products using adipose-derived stem cells in South Korea and internationally. The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn’s fistula; Queencell, a stromal vascular fraction used for the regeneration of subcutaneous adipose tissue; and Remodulin injection, a medicine for the treatment of pulmonary arterial hypertension. It also provides cosmetics, such as hair care products comprising SCM2 and SCM2-Black; and skin care products, such as Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione, as well as stem cell media program set, a cosmetic raw material. In addition, the company offers stem cell banking services; and analysis services that include sample analysis for clinical studies, as well as conducts biopharmaceutical tests for identification, purity, potency, adventitious virus, etc. Anterogen.Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.

Compare 065660 to Peers and Sector

Metrics to compare
065660
Peers
Sector
Relationship
P/E Ratio
−95.7x−8.0x−0.5x
PEG Ratio
−3.23−0.050.00
Price/Book
2.5x2.8x2.6x
Price / LTM Sales
33.1x14.9x3.3x
Upside (Analyst Target)
-0.0%42.8%
Fair Value Upside
Unlock11.4%6.5%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-71.00 / --
Revenue / Forecast
1.60B / --
EPS Revisions
Last 90 days

065660 Income Statement

FAQ

What Stock Exchange Does Anterogen Trade On?

Anterogen is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Anterogen?

The stock symbol for Anterogen is "065660."

What Is the Anterogen Market Cap?

As of today, Anterogen market cap is 231.64B.

What Is Anterogen's Earnings Per Share (TTM)?

The Anterogen EPS (TTM) is -247.30.

From a Technical Analysis Perspective, Is 065660 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Anterogen Stock Split?

Anterogen has split 0 times.

How Many Employees Does Anterogen Have?

Anterogen has 0 employees.

What is the current trading status of Anterogen (065660)?

As of 06 Aug 2025, Anterogen (065660) is trading at a price of 24,000.00, with a previous close of 23,150.00. The stock has fluctuated within a day range of 22,900.00 to 24,000.00, while its 52-week range spans from 13,700.00 to 29,650.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.